| Title | Experimental Hematology and Oncology |
| Abbreviation | Exp. Hematol. Oncol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q1); Hematology (Q1); Oncology (Q1) |
| h-index | 42 |
| Overall Rank/Ranking | 1008 |
| SCImago Journal Rank (SJR) | 2.384 |
| Impact Score | 6.15 |
| Publisher | BioMed Central Ltd |
| Country | United Kingdom |
| ISSN | 21623619 |
| Best Quartile | Q1 |
| Coverage History | 2012-2023 |
Experimental Hematology and Oncology is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Hematology (Q1); Oncology (Q1). It is published by BioMed Central Ltd. The overall rank of Experimental Hematology and Oncology is 1008. According to SCImago Journal Rank (SJR), this journal is ranked 2.384. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 42. The best quartile for this journal is Q1.
The ISSN of Experimental Hematology and Oncology journal is 21623619. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Experimental Hematology and Oncology is cited by a total of 1426 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Experimental Hematology and Oncology is 6.15, which is computed in 2024 as per its definition. Experimental Hematology and Oncology IF is decreased by a factor of 2.5 and approximate percentage change is -28.9% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Experimental Hematology and Oncology is 6.15. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 6.15 |
| 2022 | 8.65 |
| 2021 | 7.07 |
| 2020 | 4.27 |
| 2019 | 3.65 |
| 2018 | 3.02 |
| 2017 | 2.97 |
| 2016 | 3.19 |
| 2015 | 2.51 |
| 2014 | 2.93 |
Experimental Hematology and Oncology has an h-index of 42. It means 42 articles of this journal have more than 42 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Experimental Hematology and Oncology is 21623619. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Experimental Hematology and Oncology is 1008. According to SCImago Journal Rank (SJR), this journal is ranked 2.384. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.384 |
| 2022 | 1.908 |
| 2021 | 1.301 |
| 2020 | 1.223 |
| 2019 | 0.941 |
| 2018 | 0.988 |
| 2017 | 0.842 |
| 2016 | 0.992 |
| 2015 | 0.971 |
| 2014 | 0.845 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1008 |
| 2022 | 1427 |
| 2021 | 2682 |
| 2020 | 3207 |
| 2019 | 4738 |
| 2018 | 4436 |
| 2017 | 5477 |
| 2016 | 4475 |
| 2015 | 4626 |
| 2014 | 5370 |
Experimental Hematology and Oncology is published by BioMed Central Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2012-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Experimental Hematology and Oncology is Exp. Hematol. Oncol.. This abbreviation ('Exp. Hematol. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q1); Hematology (Q1); Oncology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Experimental Hematology and Oncology latest impact IF is 6.15. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 8.65 (2022) and 2.51 (2015), respectively, in the last 10 years. Moreover, its average IS is 4.44 in the previous 10 years.
The Experimental Hematology and Oncology has an SJR (SCImago Journal Rank) of 2.384, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 2.384 in 2023 and the lowest being 0.842 in 2017. Furthermore, the average SJR of the Experimental Hematology and Oncology over the previous 10-year period stands at 4.44.
The latest h-index of the Experimental Hematology and Oncology is 42.
The Experimental Hematology and Oncology is published by the BioMed Central Ltd, with its country of publication being the United Kingdom.
The Experimental Hematology and Oncology is currently ranked 1008 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1008 in 2023 and its lowest position of 5477 in 2017.
The standard ISO4 abbreviation for the Experimental Hematology and Oncology is Exp. Hematol. Oncol..
Experimental Hematology and Oncology is classified as a journal that the BioMed Central Ltd publishes.
The Experimental Hematology and Oncology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Experimental Hematology and Oncology is assigned the following International Standard Serial Numbers (ISSN): 21623619.
The best quartile for the Experimental Hematology and Oncology is Q1 (2023).
The Experimental Hematology and Oncology coverage history can be summarized as follows: 2012-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Field Archaeology | journal | 5619 | Maney Publishing | 45 | 1.64 |
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| International Journal of Applied Linguistics | journal | 6241 | Wiley-Blackwell Publishing Ltd | 53 | 1.91 |
| World Englishes | journal | 3418 | Wiley-Blackwell | 64 | 1.64 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 16153 | Taylor and Francis Ltd. | 25 | 1.10 |
| European Journal of Education | journal | 4662 | Wiley-Blackwell Publishing Ltd | 59 | 3.64 |
| Libyan Studies | journal | 19526 | Cambridge University Press | 9 | 0.30 |
| Journal of Immigrant and Refugee Studies | journal | 8890 | Routledge | 36 | 2.04 |
| Journal of Imaging Science and Technology | journal | 17857 | Society for Imaging Science and Technology | 45 | 0.68 |
| Consulting engineer Barrington | journal | 24079 | Cahners Pub. Co. | 0 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 6.15 |
| 2022 | 8.65 |
| 2021 | 7.07 |
| 2020 | 4.27 |
| 2019 | 3.65 |
| 2018 | 3.02 |
| 2017 | 2.97 |
| 2016 | 3.19 |
| 2015 | 2.51 |
| 2014 | 2.93 |
